Optimal Dose of Sunitinib for Long-Term Treatment in Japanese Patients With RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Optimal Dose of Sunitinib for Long-Term Treatment in Japanese Patients With Renal Cell Carcinoma
Cancer Chemother. Pharmacol. 2019 Sep 03;[EPub Ahead of Print], Y Yamada, Y Ohno, Y Kato, R Kobayashi, H Hayashi, S Miyahara, K Nakane, K Mizutani, S Yokoi, H Fujii, H Iihara, T Ishihara, T Deguchi, T Sugiyama, A SuzukiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.